{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:55:43Z","timestamp":1790009743868,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the STI2030-Major Projects","award":["No.2021ZD0201802"],"award-info":[{"award-number":["No.2021ZD0201802"]}]},{"name":"the Key Project of the National Natural Science Foundation of China","award":["U20A20354"],"award-info":[{"award-number":["U20A20354"]}]},{"name":"Beijing Brain Initiative from Beijing Municipal Science & Technology Commission","award":["Z201100005520016, Z201100005520017"],"award-info":[{"award-number":["Z201100005520016, Z201100005520017"]}]},{"name":"the grant from the Chinese Institutes for Medical Research","award":["CX23YZ15"],"award-info":[{"award-number":["CX23YZ15"]}]},{"name":"the National Key Scientific Instrument and Equipment Development Project","award":["31627803"],"award-info":[{"award-number":["31627803"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05500-5","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:27:54Z","timestamp":1763713674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trofinetide Improves Cognitive Function in APP\/PS1 Mice by Suppressing Inflammation and Apoptosis"],"prefix":"10.1007","volume":"63","author":[{"given":"Meilin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuye","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"10284","key":"5500_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590","journal-title":"Lancet"},{"issue":"3","key":"5500_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky R, Jessen F, Grimmer T et al (2023) Anti-amyloid antibody therapies in Alzheimer\u2019s disease. Brain 146(3):842\u2013849","journal-title":"Brain"},{"issue":"1","key":"5500_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther 9(1):211","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"5500_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41582-020-0397-4","volume":"16","author":"C Ballard","year":"2020","unstructured":"Ballard C, Aarsland D, Cummings J et al (2020) Drug repositioning and repurposing for Alzheimer disease. Nat Rev Neurol 16(12):661\u2013673","journal-title":"Nat Rev Neurol"},{"key":"5500_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/1178626419842176","volume":"12","author":"MS Lewitt","year":"2019","unstructured":"Lewitt MS, Boyd GW (2019) The role of insulin-like growth factors and insulin-like growth factor-binding proteins in the nervous system. Biochem Insights 12:1178626419842176","journal-title":"Biochem Insights"},{"issue":"8","key":"5500_CR6","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41380-023-02136-6","volume":"28","author":"A Nu\u00f1ez","year":"2023","unstructured":"Nu\u00f1ez A, Zegarra-Valdivia J, Fernandez de Sevilla D, Pignatelli J, Torres Aleman I (2023) The neurobiology of insulin-like growth factor I: from neuroprotection to modulation of brain states. Mol Psychiatry 28(8):3220\u201330","journal-title":"Mol Psychiatry"},{"key":"5500_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.672392","volume":"12","author":"AJ Montivero","year":"2021","unstructured":"Montivero AJ, Ghersi MS, Silvero CMJ et al (2021) Early IGF-1 gene therapy prevented oxidative stress and cognitive deficits induced by traumatic brain injury. Front Pharmacol 12:672392","journal-title":"Front Pharmacol"},{"key":"5500_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.brainresbull.2021.07.023","volume":"175","author":"ML Herrera","year":"2021","unstructured":"Herrera ML, Band\u00edn S, Champarini LG, Here\u00f1\u00fa CB, Bellini MJ (2021) Intramuscular insulin-like growth factor-1 gene therapy modulates reactive microglia after traumatic brain injury. Brain Res Bull 175:196\u2013204","journal-title":"Brain Res Bull"},{"key":"5500_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104896","volume":"142","author":"S Bhalla","year":"2022","unstructured":"Bhalla S, Mehan S, Khan A, Rehman MU (2022) Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions. Neurosci Biobehav Rev 142:104896","journal-title":"Neurosci Biobehav Rev"},{"key":"5500_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112441","author":"VE Bianchi","year":"2017","unstructured":"Bianchi VE, Locatelli V, Rizzi L (2017) Neurotrophic and neuroregenerative effects of GH\/IGF1. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18112441","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5500_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ghir.2004.11.004","volume":"15","author":"LI Arwert","year":"2005","unstructured":"Arwert LI, Deijen JB, Witlox J, Drent ML (2005) The influence of growth hormone (GH) substitution on patient-reported outcomes and cognitive functions in GH-deficient patients: a meta-analysis. Growth Horm IGF Res 15(1):47\u201354","journal-title":"Growth Horm IGF Res"},{"issue":"6","key":"5500_CR12","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1210\/clinem\/dgab121","volume":"106","author":"A Salzmann","year":"2021","unstructured":"Salzmann A, James SN, Williams DM et al (2021) Investigating the relationship between IGF-I, IGF-II, and IGFBP-3 concentrations and later-life cognition and brain volume. J Clin Endocrinol Metab 106(6):1617\u20131629","journal-title":"J Clin Endocrinol Metab"},{"key":"5500_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126434","author":"A Kasprzak","year":"2021","unstructured":"Kasprzak A (2021) Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22126434","journal-title":"Int J Mol Sci"},{"key":"5500_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1093257","volume":"14","author":"W Zhong","year":"2023","unstructured":"Zhong W, Wang X, Wang Y, Sun G, Zhang J, Li Z (2023) Obesity and endocrine-related cancer: the important role of IGF-1. Front Endocrinol (Lausanne) 14:1093257","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"5500_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020217","volume":"11","author":"J Bailes","year":"2021","unstructured":"Bailes J, Soloviev M (2021) Insulin-like growth factor-1 (IGF-1) and its monitoring in medical diagnostic and in sports. Biomolecules 11(2):217","journal-title":"Biomolecules"},{"key":"5500_CR16","doi-asserted-by":"crossref","unstructured":"Collins B, Neul J (2021) Trofinetide. Glycine-proline-glutamate (GPE) analogue, treatment of Rett syndrome, treatment of fragile X syndrome. Drugs Future 46(1)","DOI":"10.1358\/dof.2021.46.1.3208246"},{"issue":"1\u20132","key":"5500_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jns.2008.12.003","volume":"278","author":"MJ Bickerdike","year":"2009","unstructured":"Bickerdike MJ, Thomas GB, Batchelor DC et al (2009) NNZ-2566: a gly-pro-glu analogue with neuroprotective efficacy in a rat model of acute focal stroke. J Neurol Sci 278(1\u20132):85\u201390","journal-title":"J Neurol Sci"},{"key":"5500_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s12017-013-8236-z","volume":"15","author":"CM Cartagena","year":"2013","unstructured":"Cartagena CM, Phillips KL, Williams GL et al (2013) Mechanism of action for NNZ-2566 anti-inflammatory effects following PBBI involves upregulation of immunomodulator ATF3. Neuromolecular Med 15:504\u2013514","journal-title":"Neuromolecular Med"},{"key":"5500_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2023.06.008","author":"H Parent","year":"2023","unstructured":"Parent H, Ferranti A, Niswender C (2023) Trofinetide: a pioneering treatment for Rett syndrome. Trends Pharmacol Sci. https:\/\/doi.org\/10.1016\/j.tips.2023.06.008","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"5500_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12017-015-8341-2","volume":"17","author":"RM Deacon","year":"2015","unstructured":"Deacon RM, Glass L, Snape M et al (2015) NNZ-2566, a novel analog of (1\u20133) IGF-1, as a potential therapeutic agent for fragile X syndrome. Neuromolecular Med 17(1):71\u201382","journal-title":"Neuromolecular Med"},{"key":"5500_CR21","doi-asserted-by":"crossref","unstructured":"Harris E (2023) Trofinetide receives FDA approval as first drug for Rett syndrome. JAMA 329(14):1142","DOI":"10.1001\/jama.2023.4003"},{"issue":"D1","key":"5500_CR22","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013D646","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"5500_CR23","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J et al (2022) DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res 50(W1):W216\u2013W221","journal-title":"Nucleic Acids Res"},{"key":"5500_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118717","volume":"336","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Liang J, Li X et al (2025) Exploring antithrombotic mechanisms and effective constituents of Lagopsis supina using an integrated strategy based on network pharmacology, molecular docking, metabolomics, and experimental verification in rats. J Ethnopharmacol 336:118717","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"5500_CR25","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1172\/JCI119424","volume":"99","author":"AJ Vidal-Puig","year":"1997","unstructured":"Vidal-Puig AJ, Considine RV, Jimenez-Li\u00f1an M et al (1997) Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 99(10):2416\u20132422","journal-title":"J Clin Invest"},{"issue":"2","key":"5500_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","volume":"199","author":"WA Pedersen","year":"2006","unstructured":"Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, Haynatzki GR (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199(2):265\u2013273","journal-title":"Exp Neurol"},{"issue":"7","key":"5500_CR27","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/npp.2010.32","volume":"35","author":"L Escribano","year":"2010","unstructured":"Escribano L, Sim\u00f3n AM, Gimeno E et al (2010) Rosiglitazone rescues memory impairment in Alzheimer\u2019s transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology 35(7):1593\u20131604","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"5500_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12640-013-9437-9","volume":"25","author":"A Prakash","year":"2014","unstructured":"Prakash A, Kumar A (2014) Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of \u03b2-amyloid animal model of Alzheimer\u2019s disease. Neurotox Res 25(4):335\u2013347","journal-title":"Neurotox Res"},{"issue":"2","key":"5500_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.expneurol.2008.12.007","volume":"216","author":"S Ji","year":"2009","unstructured":"Ji S, Kronenberg G, Balkaya M et al (2009) Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome. Exp Neurol 216(2):321\u2013328","journal-title":"Exp Neurol"},{"key":"5500_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165858","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Kabir MT, Rahman MS et al (2020) Revisiting the amyloid cascade hypothesis: from anti-A\u03b2 therapeutics to auspicious new ways for Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21165858","journal-title":"Int J Mol Sci"},{"issue":"1\u20133","key":"5500_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejphar.2011.11.039","volume":"675","author":"LM Chen","year":"2012","unstructured":"Chen LM, Lin ZY, Zhu YG et al (2012) Ginsenoside Rg1 attenuates \u03b2-amyloid generation via suppressing PPAR\u03b3-regulated BACE1 activity in N2a-APP695 cells. Eur J Pharmacol 675(1\u20133):15\u201321","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"5500_CR32","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.4103\/1673-5374.313041","volume":"16","author":"C Cervellati","year":"2021","unstructured":"Cervellati C, Valacchi G, Zuliani G (2021) BACE1 role in Alzheimer\u2019s disease and other dementias: from the theory to the practice. Neural Regen Res 16(12):2407\u20132408","journal-title":"Neural Regen Res"},{"issue":"12","key":"5500_CR33","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/jnr.23122","volume":"90","author":"G Wu","year":"2012","unstructured":"Wu G, Sankaranarayanan S, Wong J et al (2012) Characterization of plasma \u03b2-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer\u2019s disease. J Neurosci Res 90(12):2247\u20132258","journal-title":"J Neurosci Res"},{"issue":"5","key":"5500_CR34","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","volume":"83","author":"Y Shen","year":"2018","unstructured":"Shen Y, Wang H, Sun Q et al (2018) Increased plasma beta-secretase 1 may predict conversion to Alzheimer\u2019s disease dementia in individuals with mild cognitive impairment. Biol Psychiatry 83(5):447\u2013455","journal-title":"Biol Psychiatry"},{"issue":"8","key":"5500_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B et al (2021) The \u03b2-secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry 89(8):745\u2013756","journal-title":"Biol Psychiatry"},{"issue":"14","key":"5500_CR36","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","volume":"27","author":"J Zhao","year":"2007","unstructured":"Zhao J, Fu Y, Yasvoina M et al (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer\u2019s disease pathogenesis. J Neurosci 27(14):3639\u20133649","journal-title":"J Neurosci"},{"issue":"3","key":"5500_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","volume":"126","author":"PC Kandalepas","year":"2013","unstructured":"Kandalepas PC, Sadleir KR, Eimer WA, Zhao J, Nicholson DA, Vassar R (2013) The Alzheimer\u2019s \u03b2-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol 126(3):329\u2013352","journal-title":"Acta Neuropathol"},{"issue":"2","key":"5500_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-016-1558-9","volume":"132","author":"KR Sadleir","year":"2016","unstructured":"Sadleir KR, Kandalepas PC, Buggia-Pr\u00e9vot V, Nicholson DA, Thinakaran G, Vassar R (2016) Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased A\u03b2 generation in Alzheimer\u2019s disease. Acta Neuropathol 132(2):235\u2013256","journal-title":"Acta Neuropathol"},{"key":"5500_CR39","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1007\/s12035-016-9874-6","volume":"54","author":"X Wang","year":"2017","unstructured":"Wang X, Wang Y, Hu J-P et al (2017) Astragaloside IV, a natural PPAR\u03b3 agonist, reduces A\u03b2 production in Alzheimer\u2019s disease through inhibition of BACE1. Mol Neurobiol 54:2939\u20132949","journal-title":"Mol Neurobiol"},{"issue":"7","key":"5500_CR40","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/mp.2011.128","volume":"17","author":"AM Fernandez","year":"2012","unstructured":"Fernandez AM, Jimenez S, Mecha M et al (2012) Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer\u2019s pathology. Mol Psychiatry 17(7):705\u2013718","journal-title":"Mol Psychiatry"},{"key":"5500_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168972","author":"E Sun","year":"2022","unstructured":"Sun E, Motolani A, Campos L, Lu T (2022) The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23168972","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5500_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1017\/S1461145711000149","volume":"15","author":"C-H Chen","year":"2012","unstructured":"Chen C-H, Zhou W, Liu S et al (2012) Increased NF-\u03baB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer\u2019s disease. Int J Neuropsychopharmacol 15(1):77\u201390","journal-title":"Int J Neuropsychopharmacol"},{"key":"5500_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00118","volume":"9","author":"WM Snow","year":"2016","unstructured":"Snow WM, Albensi BC (2016) Neuronal gene targets of NF-\u03baB and their dysregulation in Alzheimer\u2019s disease. Front Mol Neurosci 9:118","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"5500_CR44","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0006-8993(01)02018-2","volume":"898","author":"JH Su","year":"2001","unstructured":"Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW (2001) Activated caspase-3 expression in Alzheimer\u2019s and aged control brain: correlation with Alzheimer pathology. Brain Res 898(2):350\u2013357","journal-title":"Brain Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05500-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05500-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05500-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:27:55Z","timestamp":1763713675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05500-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5500"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05500-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}